Farid, K.M.N.; Sauer, T.; Schmitt, M.; Müller-Tidow, C.; Schmitt, A.
Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis. Cancers 2024, 16, 58.
https://doi.org/10.3390/cancers16010058
AMA Style
Farid KMN, Sauer T, Schmitt M, Müller-Tidow C, Schmitt A.
Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis. Cancers. 2024; 16(1):58.
https://doi.org/10.3390/cancers16010058
Chicago/Turabian Style
Farid, Kiavasch Mohammad Nejad, Tim Sauer, Michael Schmitt, Carsten Müller-Tidow, and Anita Schmitt.
2024. "Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis" Cancers 16, no. 1: 58.
https://doi.org/10.3390/cancers16010058
APA Style
Farid, K. M. N., Sauer, T., Schmitt, M., Müller-Tidow, C., & Schmitt, A.
(2024). Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis. Cancers, 16(1), 58.
https://doi.org/10.3390/cancers16010058